IRVINE, Calif.--(BUSINESS WIRE)--NeurOptics, the worldwide leader in the science of pupillometry, today announced the U.S. launch of its NPi ®-300, a next-generation automated pupillometer that ...

Automated pupillometry and the Neurological Pupil index™ (NPi®) emerge as critical tools for assessing patients at risk of brain injury across a broad spectrum of diagnoses IRVINE, Calif.--(BUSINESS ...

NeurOptics' NPi®-300, a next-generation pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, is now available globally in 15 countries. NPi-300 Pupillometer & the ...

NPi-300 Pupillometer and the Neurological Pupil index™ (NPi®) represent the gold standard in automated pupillary assessment for patients at risk of brain injury NeurOptics, the worldwide leader in the ...

The NPi Pupillometer supports neurological examination in adult and pediatric patients across a broad spectrum of diagnoses, including traumatic brain injury, stroke, seizure, or other neurological ...

NeurOptics® is the leader in the science of pupillometry and NPi®. Driven by a passion to help clinicians improve patient outcomes, NeurOptics develops and markets innovative technologies facilitating ...

NPi-200 (Neuroptics) is a handheld automated pupillometer that includes a camera and a colour touch screen. It provides precise, accurate and objective measurements of pupil size and pupillary light ...

A literature search was carried out for this briefing in accordance with NICE's interim process and methods statement for the production of medtech innovation briefings. This briefing includes the ...